NDC 71610-325

Tadalafil

Tadalafil

Tadalafil is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, Llc. The primary component is Tadalafil.

Product ID71610-325_6d71597b-631f-41b8-984b-d53aa6ca10d3
NDC71610-325
Product TypeHuman Prescription Drug
Proprietary NameTadalafil
Generic NameTadalafil
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2019-03-26
Marketing CategoryANDA / ANDA
Application NumberANDA208934
Labeler NameAphena Pharma Solutions - Tennessee, LLC
Substance NameTADALAFIL
Active Ingredient Strength20 mg/1
Pharm ClassesPhosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 71610-325-04

4 TABLET, FILM COATED in 1 BOTTLE (71610-325-04)
Marketing Start Date2019-08-13
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71610-325-06 [71610032506]

Tadalafil TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA208934
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-08-16

NDC 71610-325-12 [71610032512]

Tadalafil TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA208934
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-08-13

NDC 71610-325-04 [71610032504]

Tadalafil TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA208934
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-08-13

Drug Details

Active Ingredients

IngredientStrength
TADALAFIL20 mg/1

OpenFDA Data

SPL SET ID:059b4496-bbfd-4058-ab03-91c5c223b945
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 402019
  • 403957

    • Pharmacological Class

    • Phosphodiesterase 5 Inhibitor [EPC]
    • Phosphodiesterase 5 Inhibitors [MoA]
    • Phosphodiesterase 5 Inhibitor [EPC]
    • Phosphodiesterase 5 Inhibitors [MoA]

    NDC Crossover Matching brand name "Tadalafil" or generic name "Tadalafil"

    NDCBrand NameGeneric Name
    0093-3016TadalafilTadalafil
    0093-3017TadalafilTadalafil
    0093-3018TadalafilTadalafil
    0093-3019TadalafilTadalafil
    68180-914TadalafilTadalafil
    68382-896TadalafilTadalafil
    68382-898TadalafilTadalafil
    68382-897TadalafilTadalafil
    68382-899TadalafilTadalafil
    69097-376TadalafilTadalafil
    69097-375TadalafilTadalafil
    69097-373TadalafilTadalafil
    69097-526TadalafilTadalafil
    69097-374TadalafilTadalafil
    69238-1347TadalafilTadalafil
    69238-1346TadalafilTadalafil
    69238-1348TadalafilTadalafil
    69238-1349TadalafilTadalafil
    70771-1476TadalafilTadalafil
    70771-1477TadalafilTadalafil
    70771-1478TadalafilTadalafil
    70771-1475TadalafilTadalafil
    71610-214TadalafilTadalafil
    71610-213TadalafilTadalafil
    13668-568TADALAFILTADALAFIL
    13668-566TADALAFILTADALAFIL
    13668-567TADALAFILTADALAFIL
    13668-565TADALAFILTADALAFIL
    13668-581TADALAFILTADALAFIL
    16729-370TadalafilTadalafil
    16729-372TadalafilTadalafil
    16729-369TadalafilTadalafil
    27241-123TadalafilTadalafil
    27241-111TadalafilTadalafil
    27241-112TadalafilTadalafil
    29300-289tadalafiltadalafil
    29300-288tadalafiltadalafil
    27241-114TadalafilTadalafil
    27241-113TadalafilTadalafil
    31722-646TadalafilTadalafil
    29300-286tadalafiltadalafil
    31722-645TadalafilTadalafil
    29300-287tadalafiltadalafil
    31722-643TadalafilTadalafil
    31722-647TadalafilTadalafil
    31722-644TadalafilTadalafil
    35573-411TadalafilTadalafil
    35573-410TadalafilTadalafil
    35573-412TadalafilTadalafil
    35573-409TadalafilTadalafil
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.